company background image
HPL logo

Hoechst Pakistan KASE:HPL Stock Report

Last Price

PK₨1.60k

Market Cap

PK₨15.4b

7D

0.06%

1Y

128.6%

Updated

21 Jun, 2024

Data

Company Financials

Hoechst Pakistan Limited

KASE:HPL Stock Report

Market Cap: PK₨15.4b

HPL Stock Overview

Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.

HPL fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends3/6

Hoechst Pakistan Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hoechst Pakistan
Historical stock prices
Current Share PricePK₨1,600.00
52 Week HighPK₨1,625.00
52 Week LowPK₨650.00
Beta0.28
11 Month Change16.81%
3 Month Change18.18%
1 Year Change128.57%
33 Year Change64.95%
5 Year Change164.46%
Change since IPO1,128.41%

Recent News & Updates

Recent updates

Shareholder Returns

HPLPK PharmaceuticalsPK Market
7D0.06%-0.7%2.0%
1Y128.6%87.9%65.5%

Return vs Industry: HPL exceeded the PK Pharmaceuticals industry which returned 91.3% over the past year.

Return vs Market: HPL exceeded the PK Market which returned 64.4% over the past year.

Price Volatility

Is HPL's price volatile compared to industry and market?
HPL volatility
HPL Average Weekly Movement8.8%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement5.3%
10% most volatile stocks in PK Market8.2%
10% least volatile stocks in PK Market3.2%

Stable Share Price: HPL has not had significant price volatility in the past 3 months.

Volatility Over Time: HPL's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of PK stocks.

About the Company

FoundedEmployeesCEOWebsite
1967734Sajjad Iftikharwww.hoechst.com.pk

Hoechst Pakistan Limited engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally. The company provides its antibiotic, cardiology, diabetes, pain and allergy, and other products under Flagyl, Clexane, NO-SPA, Lantus, Amaryl, Claforan, Haemaccel, Enterogermina, and Plavix brands. It also offers various shampoos under the Selsun Blue brand name.

Hoechst Pakistan Limited Fundamentals Summary

How do Hoechst Pakistan's earnings and revenue compare to its market cap?
HPL fundamental statistics
Market capPK₨15.43b
Earnings (TTM)PK₨1.05b
Revenue (TTM)PK₨22.89b

14.6x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HPL income statement (TTM)
RevenuePK₨22.89b
Cost of RevenuePK₨17.38b
Gross ProfitPK₨5.51b
Other ExpensesPK₨4.46b
EarningsPK₨1.05b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)109.26
Gross Margin24.08%
Net Profit Margin4.60%
Debt/Equity Ratio0.03%

How did HPL perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

27%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.